Feed / VKTX

Viking Therapeutics, Inc.

VKTX

Healthcare · 34.17 +2.9% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

Viking Therapeutics, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 8 directly disclosed connections are confirming.

Company+2.9% todayVolume comparison unavailable
Market group0 of 37 activeBiotechnology · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • VKTX's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if VKTX's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind VKTX

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

LGNDLigand Pharmaceuticals IncorporatedpartnerOct 23, 2025

Our primary use of cash is to fund operating expenses, which to date have consisted of the cost to obtain the license of intellectual property from Ligand, certain research and development expenses related to furthering the development of VK2735 subcutaneous,…

AMGNAmgen Inc.competitorApr 30, 2026

We are also aware of several programs targeting obesity that are in the late development stage that will compete against VK2735, if approved, including CagriSema from Novo Nordisk A/S, retatrutide from Eli Lilly and Company, survodutide (BI 456906) from Boehr…

Depended on by

PTGXProtagonist Therapeutics, Inc.partnerFeb 25, 2026

VK2735 (Viking Therapeutics) is a dual GLP-1/GIP receptor agonist in Phase 3 development for subcutaneous administration, with an oral formulation in mid-stage clinical development.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 10 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

VKTX is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.